KVP Capital Advisors
Latest statistics and disclosures from KVP Capital Advisors's latest quarterly 13F-HR filing:
- Top 5 stock holdings are TERN, PRAX, WHWK, AXSM, STRO, and represent 42.01% of KVP Capital Advisors's stock portfolio.
- Added to shares of these 10 stocks: STRO (+$5.6M), ERAS (+$5.5M), TNGX, IDYA, CMPX, OCUL, VRDN, DRUG, ZURA, RVMD.
- Started 9 new stock positions in DRUG, ERAS, ZURA, CMPX, TNGX, STRO, OCUL, VRDN, IDYA.
- Reduced shares in these 4 stocks: , , Fulcrum Therapeutics, FULC.
- Sold out of its positions in FULC, Fulcrum Therapeutics, JAZZ, Jazz Pharmaceuticals Plc cmn.
- KVP Capital Advisors was a net buyer of stock by $22M.
- KVP Capital Advisors has $134M in assets under management (AUM), dropping by 29.57%.
- Central Index Key (CIK): 0001858198
Tip: Access up to 7 years of quarterly data
Positions held by KVP Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for KVP Capital Advisors
KVP Capital Advisors holds 32 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Terns Pharmaceuticals (TERN) | 17.3 | $23M | 440k | 52.72 |
|
|
| Praxis Precision Medicines I Com New (PRAX) | 10.3 | $14M | 43k | 322.19 |
|
|
| Aadi Bioscience (WHWK) | 5.6 | $7.5M | 2.2M | 3.45 |
|
|
| Axsome Therapeutics (AXSM) | 4.6 | $6.1M | 36k | 169.02 |
|
|
| Sutro Biopharma Com Shs (STRO) | 4.2 | $5.6M | NEW | 227k | 24.91 |
|
| Protagonist Therapeutics (PTGX) | 4.2 | $5.6M | 53k | 105.40 |
|
|
| Erasca (ERAS) | 4.1 | $5.5M | NEW | 340k | 16.18 |
|
| Trevi Therapeutics (TRVI) | 3.7 | $4.9M | 414k | 11.93 |
|
|
| Tango Therapeutics (TNGX) | 3.6 | $4.8M | NEW | 230k | 20.92 |
|
| Insmed Com Par $.01 (INSM) | 3.5 | $4.7M | 29k | 163.52 |
|
|
| Edgewise Therapeutics (EWTX) | 3.1 | $4.2M | 133k | 31.50 |
|
|
| Revolution Medicines (RVMD) | 2.9 | $3.9M | +46% | 40k | 97.25 |
|
| Disc Medicine (IRON) | 2.8 | $3.7M | 58k | 63.94 |
|
|
| Mbx Biosciences (MBX) | 2.7 | $3.6M | 122k | 29.85 |
|
|
| Savara (SVRA) | 2.5 | $3.3M | 605k | 5.46 |
|
|
| United Therapeutics Corporation (UTHR) | 2.1 | $2.8M | 4.8k | 592.98 |
|
|
| Travere Therapeutics (TVTX) | 2.0 | $2.7M | 91k | 29.71 |
|
|
| Ideaya Biosciences (IDYA) | 2.0 | $2.7M | NEW | 80k | 33.32 |
|
| Compass Therapeutics (CMPX) | 2.0 | $2.6M | NEW | 500k | 5.29 |
|
| Ocular Therapeutix (OCUL) | 1.9 | $2.5M | NEW | 300k | 8.47 |
|
| Miragen Therapeutics (VRDN) | 1.8 | $2.4M | NEW | 125k | 19.56 |
|
| Bright Minds Biosciences Com New (DRUG) | 1.7 | $2.3M | NEW | 32k | 72.97 |
|
| Zura Bio Class A Ord Shs (ZURA) | 1.7 | $2.2M | NEW | 373k | 5.95 |
|
| Scholar Rock Hldg Corp (SRRK) | 1.7 | $2.2M | 45k | 49.16 |
|
|
| Immix Biopharma (IMMX) | 1.6 | $2.1M | 230k | 9.11 |
|
|
| Soleno Therapeutics (SLNO) | 1.5 | $2.0M | 60k | 33.48 |
|
|
| Nektar Therapeutics Com New (NKTR) | 1.4 | $1.9M | 27k | 71.95 |
|
|
| Cabaletta Bio (CABA) | 1.0 | $1.4M | 505k | 2.69 |
|
|
| Achieve Life Sciences (ACHV) | 1.0 | $1.4M | 462k | 2.94 |
|
|
| Vera Therapeutics Cl A (VERA) | 1.0 | $1.3M | 33k | 40.23 |
|
|
| Celcuity (CELC) | 0.3 | $457k | 4.0k | 114.14 |
|
|
| Vyne Therapeutics (VYNE) | 0.2 | $299k | 501k | 0.60 |
|
Past Filings by KVP Capital Advisors
SEC 13F filings are viewable for KVP Capital Advisors going back to 2025
- KVP Capital Advisors 2026 Q1 filed May 13, 2026
- KVP Capital Advisors 2025 Q4 filed Feb. 18, 2026